摘要:
The invention concerns a compound of formula (I), wherein (a) represents a single or double bond; (b) represents a cycle selected among (i), (ii), (iii), (iv), (v), (vi) and (vii). The inventive compounds, besides their novelty, exhibit very interesting antitumour properties.
摘要:
The invention relates to compounds of formula (I), wherein R1 is a group selected from hydrogen, alkyl, aryl, aryalkil, heteroaryl, heteroarylalkyl, alkylcarbonyl, arylcarbonyl, arylalkylcarbonyl, alkoxycarbonyl, aryloxycarbonyl, arylalkoxycarbonyl, heterocycloalkoxycarbonyl, alkylsulfonyl, arylsulfonyl, arylalkylsulfonyl, phosphonic and Si(Ra)2Rb, Y is a group selected from HN-NH and N-R2, R3 is a hydrogen atom, an alkyl, cycloalkyl, aryl, arylalkyl group, R4 is hydrogen atom or an alkyl group, enantiomers, diastereoisomers and the salts thereof.
摘要:
The invention relates to compounds of formula (I), wherein R1 is a group selected from hydrogen, alkyl, aryl, aryalkil, heteroaryl, heteroarylalkyl, alkylcarbonyl, arylcarbonyl, arylalkylcarbonyl, alkoxycarbonyl, aryloxycarbonyl, arylalkoxycarbonyl, heterocycloalkoxycarbonyl, alkylsulfonyl, arylsulfonyl, arylalkylsulfonyl, phosphonic and Si(Ra)2Rb, Y is a group selected from HN-NH and N-R2, R3 is a hydrogen atom, an alkyl, cycloalkyl, aryl, arylalkyl group, R4 is hydrogen atom or an alkyl group, enantiomers, diastereoisomers and the salts thereof.
摘要:
The invention concerns compounds of formula (I), wherein: Z represents a group of formula U-V such as defined in the description; W1 represents, with the carbon atoms to which it is bound, a phenyl group or a pyridinyl group; W2 is such as defined in the description; X1, X2 represent each a hydrogen atom, a hydroxy, alkoxy, mercapto or alkylthio group; Y1, Y2 represent each a hydrogen atom, or X1 and Y1, X2 and Y2 represent each a hydrogen atom, a hydroxy, a linear or branched C1-C6 alkoxy, mercapto, and linear or branched C1-C6 alkythio group; R1 is such as defined in the description; Q represents an oxygen atom or a NR2 group such as defined in the description.
摘要:
Compounds of formula (I) wherein: WI and W2 represent, with the carbon atoms to which they are bound, a phenyl group or a pyridinyl group, and at least one of the groups W1 or W2 represent a pyridinyl group; R1 and R2 each represent a group of formula U-V as defined in the description, X and X1 each represent a hydrogen atom, a hydroxy, alkoxy, mercapto or alkylthio group; Y and Y1 each represent a hydrogen atom; or X and Y, X1 and Y1 represent, together with the carbon atom that they include, a carbonyl or thiocarbonyl group; R4 and R5 are as defined in the description; Q1, Q2 represent a hydrogen atom, or Q1 and Q2, together with the carbon atoms that they include, form an aromatic link. The inventive compounds are used in medicaments.
摘要:
The invention concerns compounds of formula (I), wherein: A is such as described in the description; Y represents a group selected among an oxygen atom or a methylene group; R2 represents a hydrogen atom, in which case: R3 represents a group selected among a hydrogen atom, a C1-C6 linear or branched alkyl, aryl, linear or branched C1-C6 arylalkyl group, or SO2CF3, or R2 and R3 form a bond; R1 represents a group selected among a hydrogen atom, a C1-C6 linear or branched alkyl, aryl, linear or branched C1-C6 arylalkyl group, or a linear or branched C1-C6 alkylene chain; Z1 and Z2 represent each a hydrogen atom or Z1 and Z2 form together, with the carbon atoms bearing them, a phenyl group. The invention is useful for preparing medicines.
摘要:
A compound selected from these of formula (I):wherein:R1 represents hydrogen, alkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, alkoxycarbonyl, aryloxycarbonyl, arylalkoxycarbonyl, heterocycloalkoxycarbonyl, alkylsulfonyl, arylsulfonyl, arylalkylsulfonyl or phosphono,R2 represents oxygen or sulphur,R3 represents hydrogen or alkyl, cycloalkyl or arylalkyl,X represents linear or branched (C1-C6)alkylene,R4 represents a group selected from amino optionally substituted by one or two groups, -N(R3)-X1-OR5 wherein R3, X1 and R5 are as defined in the description, -N(R3)-X1-NR6R7 wherein R3, X1, R6 and R7 are as defined in the description, hydroxy, alkoxy, aryloxy, -O-X1-OR5 wherein R5 and X1 are as defined in the description, and -O-X1-NR6R7 wherein R6, R7 and X1 are as defined in the description,its isomers, and also addition salts thereof with a pharmaceutically acceptable acid or base, and medical products containing the same which are useful in the treatment of cancer.